13 completed, 6 unknown, 1 recruiting, 1 withdrawn. 10 Not applicable, 4 Phase 3, 2 Phase 1, 2 Phase 4, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 10 | Unknown 5, Completed 4, Recruiting 1 |
| Phase 3 | 4 | Completed 2, Unknown 1, Withdrawn 1 |
| Phase 1 | 2 | Completed 2 |
| Phase 4 | 2 | Completed 2 |
| Phase 2 | 1 | Unknown 1 |
Follow Intravitreal injection: new trials by email Literature Review of Intravitreal injection trials Research Report on Intravitreal injection
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Durability of Three Monthly Loading Doses With Faricimab in Treatment-naïve Neovascular Age-related Macular Degeneration Faricimab Injection [Vabysmo] - Neovascular Age-Related Macular Degeneration (nAMD), Treatment-naïve | Completed | Copenhagen University Hospital, Rigshospitalet | 742 | 2024-11-15 | 2026-03-27 | |
| Real-world Incidence of Intraocular Inflammation Following Intravitreal Faricimab Therapy Faricimab Injection [Vabysmo] - Intraocular Inflammation | Completed | Copenhagen University Hospital, Rigshospitalet | 6053 | 2024-11-10 | 2025-03-30 | |
| Brolucizumab for CNV Associated With Pathologic Myopia Intravitreal injection - Pathologic Myopia | Not applicable | Unknown | The Filatov Institute of Eye Diseases and Tissue Therapy | 50 | 2021-04-01 | 2022-03-24 |
| BEOVU Versus Eylea in the Treatment of Age-related Macular Neovascular Degeneration intravitreal injection - Macula Lutea Degeneration | Not applicable | Unknown | Benha University | 40 | 2020-08-05 | 2021-05-12 |
| A Study to Evaluate the Safety and Tolerability of ONL1204 in Patients With Macula-off, Rhegmatogenous Retinal Detachment ONL1204, Intravitreal Injection, Collection of ocular fluids - Rhegmatogenous Retinal Detachment - Macula Off | Phase 1 | Completed | ONL Therapeutics | 14 | 2019-10-21 | 2024-09-24 |
| PPV With Internal Limiting Membrane Peeling for Treatment-Naïve DME PPV/MP, Intravitreal injection - Diabetic Retinopathy, Macular Edema | Phase 3 | Completed | Rush Eye Associates | 11 | 2018-09-04 | 2021-12-02 |
| Intracameral Versus Intravitreal Bevacizumab Injection in NVG: RCT Intracameral injection, Intravitreal injection - Glaucoma, Neovascular, Vascular Endothelial Growth Factor Overexpression | Not applicable | Recruiting | Prince of Songkla University | 40 | 2018-08-01 | 2025-08-21 |
| Antiangiogenic Therapy of CNV Associated With Angioid Streaks Intravitreal injection - Angioid Streaks of Macula | Not applicable | Unknown | The Filatov Institute of Eye Diseases and Tissue Therapy | 100 | 2018-03-27 | 2021-02-03 |
| Antiangiogenic Therapy of Choroidal Neovascularisation Associated With Myopia Intravitreal injection - Pathologic Myopia | Not applicable | Completed | The Filatov Institute of Eye Diseases and Tissue Therapy | 122 | 2018-03-27 | 2023-01-25 |
| Antiangiogenic Therapy of Choroidal Neovascularisation Associated With Central Chorioretinitis Intravitreal injection, Fluorescent angiography, Visometry - Chorioretinitis | Not applicable | Unknown | The Filatov Institute of Eye Diseases and Tissue Therapy | 100 | 2018-03-27 | 2021-02-03 |
| The Effect of Conbercept Injection Through Different Routes for Neovascular Glaucoma Intracameral injection, Intravitreal injection - Neovascular Glaucoma | Not applicable | Completed | Second Affiliated Hospital of Xi'an Jiaotong University | 30 | 2017-04-01 | 2018-05-23 |
| Dexamethasone Intravitreal Implant in Retinal Vein Occlusion Intravitreal injection - Macular Edema, Cystoid | Completed | Università degli Studi dell'Insubria | 30 | 2015-10-01 | 2018-06-18 | |
| Assessment of Early Changes in SD-OCT After Initiation of a Treatment by Intravitreal Aflibercept (EYLEA®)START Intravitreal injection - Neovascular Age-related Macular Degeneration of All Subtypes | Phase 4 | Completed | University Hospital, Bordeaux | 50 | 2014-09-01 | 2026-09-17 |
| Plasma Levels of Vascular Endothelial Growth Factor Before and After Intravitreal Injection of Aflibercept intravitreal injection - Exudative Age-related Macular Degeneration | Phase 4 | Completed | Oslo University Hospital | 16 | 2014-04-01 | 2022-04-27 |
| Autologous Plasmin and Fibrinolytic System in Diabetic Retinopathy Intravitreal injection - Macular Edema | Not applicable | Unknown | Hallym University Medical Center | 40 | 2011-11-01 | 2011-12-02 |
| Intravitreal Bevacizumab and Triamcinolone in Diabetic Macular Edema Intravitreal injection - Diabetic Macular Edema | Not applicable | Completed | Hallym University Medical Center | 80 | 2009-03-01 | 2011-04-27 |
| Efficacy and Safety of Intravitreal Bevacizumab in the Treatment of Choroidal Neovascular Membranes Associated to High Myopia Intravitreal Injection, Photodynamic Therapy (Visudyne) - Myopia, Choroidal Neovascularization | Phase 3 | Completed | Instituto Universitario de Oftalmobiología Aplicada (Institute of Applied Ophthalmobiology) - IOBA | 56 | 2008-04-01 | 2024-10-31 |
| Triamcinolone or Bevacizumab for Central Retinal Vein Occlusion With Poor Vision intravitreal injection - Central Retinal Vein Occlusion With 20/200 or Worse Visual Acuity | Not applicable | Completed | Hallym University Medical Center | 38 | 2008-01-01 | 2010-01-22 |
| Antiangiogenic Therapy With Bevacizumab in Retinopathy of Prematurity. Structural Outcome intravitreal injection - Retinopathy of Prematurity | Phase 2 / Phase 3 | Unknown | Asociación para Evitar la Ceguera en México | 2007-07-01 | 2024-07-31 | |
| Intravitreal Bevacizumab in Agioid Streaks intravitreal injection - Angioid Streaks, Choroidal Neovascularization | Phase 1 | Completed | University of Campania Luigi Vanvitelli | 5 | 2006-11-01 | 2016-02-08 |
Showing 20 of 21. Sign in to see all of them.
Choroidal Neovascularization (5) · Macular Edema (4) · Angioid Streaks (2) · Glaucoma, Neovascular (2) · Chorioretinitis (1) · Diabetic Retinopathy (1) · Macular Degeneration (1) · Myopia (1) · Retinal Vein Occlusion (1) · Retinopathy of Prematurity (1) · Uveitis (1)
The Filatov Institute of Eye Diseases and Tissue Therapy (4) · Hallym University Medical Center (3) · Asociación para Evitar la Ceguera en México (2) · Copenhagen University Hospital, Rigshospitalet (2) · Benha University (1) · Instituto Universitario de Oftalmobiología Aplicada (Institute of Applied Ophthalmobiology) - IOBA (1) · ONL Therapeutics (1) · Oslo University Hospital (1) · Prince of Songkla University (1) · Rush Eye Associates (1) · Second Affiliated Hospital of Xi'an Jiaotong University (1) · University Hospital, Bordeaux (1) · University of Campania Luigi Vanvitelli (1) · Università degli Studi dell'Insubria (1)
Ukraine (4) · Mexico (3) · South Korea (3) · Denmark (2) · Australia (1) · China (1) · France (1) · Italy (1) · Spain (1) · Thailand (1) · United Arab Emirates (1)
Andrii MD Korol, PhD (4) · Assoc.Prof.Weerawat Kiddee, MD (1) · Griselda Alvarez, Fellow (1) · Jiwon Lim, MDPhD (1) · Ling Bai, MD,PhD (1) · Matthew Simunovic, M.D. (1) · Michele Rinaldi, MD (1) · Miklos Schneider, MD, PhD (1) · Simone Donati, MD (1) · Sloan Rush (1) · Tarek Elhamaky, MD (1)
PMID 25966740, PMID 27604764, PMID 30175123, PMID 33600134, PMID 34188440, PMID 35083234, PMID 42105126, PMID 42141825
2014 (1)